Welcome to the Dimera home page. We are a small west coast company dedicated to discovering novel medical concepts to address important medical needs (i.e., the leading cause of death and dysfunction, which is cardiovascular pathophysiology) for women and men. You are invited to visit often, as you will find frequent updates to this website that highlight cardiovascular (CV) and related (smooth muscle) research progress.
Dimera Incorporated focuses on developing safe and effective medicines to reduce the risk of heart disease and cardiovascular dysfunction by discovering and treating causes rather than symptoms. This more arduous path has important virtues, particularly from the standpoint of responding to unmet needs and minimizing side effects with maximized ease of use.
-Heart health with heart of the problem Dimera research
-Healthy women, the goal of Dimera research on novel drugs
-Innovation in preventing angina pectoris [heart dysfunction]
-References to major scientific publications for CV medicine
-Terminology to provide additional technical background
-Links to related sites on cardiovascular science and medicine
-Press release analysis of what we know about which progestins can and can't succeed
-Contact information for Dimera company & team members
Announcement--The July 2008 issue of Nature Clinical Practice Cardiovascular Medicine displays the latest Dimera peer reviewed publication on the contrast between actions on the heart of progesterone and synthetic progestins.
© 1997-2008 Dimera Incorporated